Literature DB >> 27774717

Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.

Merav Kovatch1, Daniel Feingold2,3, Odelia Elkana1, Shaul Lev-Ran4,3.   

Abstract

Prescription opioid medications are commonly used for the treatment of chronic pain. Assessments of problematic opioid use among pain patients are inconsistent across studies, partially due to differences between various measures. Therefore, the most appropriate measure to use is often unclear. In this study we assessed problematic opioid use in a sample of 551 individuals receiving treatment for chronic pain, using three questionnaires: the Alcohol Use Disorder and Associated Disabilities Interview Schedule - Fourth Edition (AUDADIS-IV), the Current Opioid Misuse Measure (COMM) questionnaire and Portenoy's criteria (PC). These questionnaires yielded discordant positive rates of problematic use: 52.6%, 28.7%, and 17.1%, respectively, which did not change substantially when excluding AUDADIS-IV criteria of physical symptoms of tolerance and withdrawal. Although these three questionnaires share some statistically correlated content-based congruent questions, positive response rates to them were significantly different based on construction features, including questionnaires' referred time-frame, wording of questions and response alternatives. The findings of the present study illustrate strengths and limitations of the AUDADIS-IV, COMM and PC in diagnosing problematic opioid use in a population of adults suffering from chronic pain, and highlight the importance of recognizing and addressing specific questionnaire and question-related differences when identifying problematic opioid use in this population.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  chronic pain; opioid; prevalence; problematic use; questionnaires

Mesh:

Year:  2016        PMID: 27774717      PMCID: PMC6877121          DOI: 10.1002/mpr.1542

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  56 in total

1.  Social desirability and probability of endorsement of items in the interpersonal check list.

Authors:  A L EDWARDS
Journal:  J Abnorm Psychol       Date:  1957-11

Review 2.  Addiction to opioids in chronic pain patients: a literature review.

Authors:  Jette Højsted; Per Sjøgren
Journal:  Eur J Pain       Date:  2006-10-27       Impact factor: 3.931

3.  Strategies to stop abuse of prescribed opioid drugs.

Authors:  Jennifer Fisher Wilson
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

Review 4.  The validity of self-reported drug use in survey research: an overview and critique of research methods.

Authors:  L Harrison
Journal:  NIDA Res Monogr       Date:  1997

Review 5.  Opioid therapy for chronic nonmalignant pain: a review of the critical issues.

Authors:  R K Portenoy
Journal:  J Pain Symptom Manage       Date:  1996-04       Impact factor: 3.612

Review 6.  Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.

Authors:  Nalini Sehgal; Laxmaiah Manchikanti; Howard S Smith
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

7.  Ability of EDI-2 and EDI-3 to correctly identify patients and subjects at risk for eating disorders.

Authors:  Cristina Segura-García; Matteo Aloi; Marianna Rania; Paola Ciambrone; Antonella Palmieri; Valentina Pugliese; Antonio José Ruiz Moruno; Pasquale De Fazio
Journal:  Eat Behav       Date:  2015-07-02

8.  Prescription of opioid analgesics and related harms in Australia.

Authors:  Amanda Roxburgh; Raimondo Bruno; Briony Larance; Lucy Burns
Journal:  Med J Aust       Date:  2011-09-05       Impact factor: 7.738

9.  Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population.

Authors:  Bernd Löwe; Oliver Decker; Stefanie Müller; Elmar Brähler; Dieter Schellberg; Wolfgang Herzog; Philipp Yorck Herzberg
Journal:  Med Care       Date:  2008-03       Impact factor: 2.983

10.  A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy.

Authors:  Steven D Passik; Kenneth L Kirsh; Laurie Whitcomb; Russell K Portenoy; Nathaniel P Katz; Leah Kleinman; Sheri L Dodd; Jeffrey R Schein
Journal:  Clin Ther       Date:  2004-04       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.